Electroacupuncture therapy for improving walking ability in elderly patients with sarcopenia
Official title: Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia:a Randomized Controlled Trial
Run by The Third Affiliated hospital of Zhejiang Chinese Medical University · NCT05431010 · Data updated 2026-11-12
This study is testing if adding electroacupuncture to rehabilitation training can help older adults with sarcopenia walk better and improve their muscle strength.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 95 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | July 2, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT05431010 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly individuals aged 60 to 95 who can walk and communicate independently and meet the diagnostic criteria for sarcopenia.
✕Probably not a fit
Patients with serious underlying health conditions, severe mental illness, or those unable to participate in rehabilitation training may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the efficacy and safety of electroacupuncture therapy combined with rehabilitation training in elderly patients diagnosed with sarcopenia. A total of 120 participants will be randomly assigned to either the electroacupuncture group or a control group receiving only rehabilitation training. The primary focus is on improving lower limb mobility, assessed through various physical performance tests, while secondary outcomes include muscle mass and strength measurements. The study will evaluate outcomes before the intervention, after 12 weeks of treatment, and at a 12-week follow-up.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance walking ability and overall mobility in elderly patients suffering from sarcopenia.
How similar studies have gone: While the efficacy of electroacupuncture in treating sarcopenia is still being explored, similar approaches in other studies have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 60 years ≤ age ≤ 95 years, male or female; 2. Patients are able to walk and communicate independently, and can complete required rehabilitation training; 3. Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS); 4. Patients volunteer to participate in this study and sign the informed consent. Exclusion Criteria: 1. Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system; 2. Patients with severe mental illness, cognitive impairment, and disorientation; 3. Patients have trauma and unsuitable for sports; 4. Patients with electronic devices or metal objects implanted in the body; 5. Patients can't complete the required rehabilitation training; 6. Patients cannot receive EA treatment due to any reasons 7. Patients are participating in other drugs, acupuncture and massage trials.
Where it's running
-
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Ming Guo, Doctor — Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Study coordinator: Wenzhe Wu, Master
- Email: 2008777.1378@163.com
- Phone: 18757570729
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.